NO20062949L - Anvendelse av cytokiner av IL-6-typen for modning av oocytter - Google Patents

Anvendelse av cytokiner av IL-6-typen for modning av oocytter

Info

Publication number
NO20062949L
NO20062949L NO20062949A NO20062949A NO20062949L NO 20062949 L NO20062949 L NO 20062949L NO 20062949 A NO20062949 A NO 20062949A NO 20062949 A NO20062949 A NO 20062949A NO 20062949 L NO20062949 L NO 20062949L
Authority
NO
Norway
Prior art keywords
cytokines
oocyte maturation
vitro
maturation
dyocytes
Prior art date
Application number
NO20062949A
Other languages
English (en)
Other versions
NO341221B1 (no
Inventor
Stephen S Palmer
Ann M Clark
Daniel Gustavo De Matos
Jennifer A Jackson
Cam Anh T Tran
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34652319&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20062949(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20062949L publication Critical patent/NO20062949L/no
Publication of NO341221B1 publication Critical patent/NO341221B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/175—Cardiotrophin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2306—Interleukin-6 (IL-6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/237—Oncostatin M [OSM]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pregnancy & Childbirth (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Anvendelse av visse cytokiner av IL-6-typen for in vitro modning av pattedyroocytter beskrives. De in vitro modnede oocyttene kan anvendes i fremgangsmåter for in vitro befiiiktning.
NO20062949A 2003-11-26 2006-06-23 Anvendelse av cytokiner av IL-6-typen for modning av oocytter NO341221B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52527903P 2003-11-26 2003-11-26
PCT/US2004/039757 WO2005054449A1 (en) 2003-11-26 2004-11-26 Use of il-6-type cytokines for maturation of oocytes

Publications (2)

Publication Number Publication Date
NO20062949L true NO20062949L (no) 2006-06-23
NO341221B1 NO341221B1 (no) 2017-09-18

Family

ID=34652319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062949A NO341221B1 (no) 2003-11-26 2006-06-23 Anvendelse av cytokiner av IL-6-typen for modning av oocytter

Country Status (14)

Country Link
US (1) US8071375B2 (no)
EP (2) EP2325201B1 (no)
JP (1) JP5144073B2 (no)
AT (1) ATE521698T1 (no)
AU (1) AU2004294572A1 (no)
CA (1) CA2544409C (no)
DK (2) DK2325201T3 (no)
ES (2) ES2610161T3 (no)
HU (1) HUE031978T2 (no)
IL (1) IL175510A (no)
NO (1) NO341221B1 (no)
PL (2) PL1697504T3 (no)
PT (2) PT2325201T (no)
WO (1) WO2005054449A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2894479A1 (en) 2011-12-14 2013-06-20 The Board Of Trustees Of The Leland Stanford Junior University Stimulation of ovarian follicle development and oocyte maturation
CA2995684A1 (en) * 2014-09-10 2016-03-17 The Board Of Trustees Of The Leland Stanford Junior University Stimulation of ovarian follicle development and oocyte maturation
WO2016094970A1 (en) * 2014-12-19 2016-06-23 Vrije Universiteit Brussel In vitro maturation of a mammalian cumulus oocyte complex
CN113444683B (zh) * 2021-07-12 2022-11-04 华南农业大学 提高卵母细胞体外成熟质量的添加剂、培养方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5563059A (en) 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
WO1997030146A2 (en) 1996-02-14 1997-08-21 Genentech, Inc. Cardiotrophin and uses therefor
CN1607391A (zh) * 1998-06-22 2005-04-20 梅迪-卡尔特公司 预测取出用于体外受精的卵细胞的时间的方法
US6274135B1 (en) * 1999-06-22 2001-08-14 Genetics Institute, Inc. Method of using IL-11 for inflammation associated with acute pancreatitis
US6762053B2 (en) 2000-06-09 2004-07-13 Vitrolife, Inc. Mammalian gamete and embryo culture media and culture media supplements
JP2005518823A (ja) 2002-03-08 2005-06-30 マクギル・ユニバーシテイ 未成熟ヒト卵母細胞の体外成熟

Also Published As

Publication number Publication date
JP5144073B2 (ja) 2013-02-13
EP2325201A1 (en) 2011-05-25
US20050142107A1 (en) 2005-06-30
ES2610161T3 (es) 2017-04-26
EP2325201B1 (en) 2016-11-09
US8071375B2 (en) 2011-12-06
PT1697504E (pt) 2011-11-08
ATE521698T1 (de) 2011-09-15
JP2007535303A (ja) 2007-12-06
IL175510A (en) 2011-03-31
IL175510A0 (en) 2006-09-05
WO2005054449A1 (en) 2005-06-16
PL1697504T3 (pl) 2012-01-31
CA2544409A1 (en) 2005-06-16
EP1697504B1 (en) 2011-08-24
PL2325201T3 (pl) 2017-05-31
AU2004294572A1 (en) 2005-06-16
PT2325201T (pt) 2017-01-09
HUE031978T2 (en) 2017-08-28
CA2544409C (en) 2014-06-10
EP1697504A1 (en) 2006-09-06
NO341221B1 (no) 2017-09-18
DK2325201T3 (en) 2017-02-20
ES2368846T3 (es) 2011-11-22
DK1697504T3 (da) 2011-11-14

Similar Documents

Publication Publication Date Title
CR7977A (es) Anilidas de acido trifluorometil-tiofencarboxilico y su uso como fungicidas
SE0302487D0 (sv) Novel compounds
DOP2001000224A (es) Composiciones farmaceuticas de inhibidores de la proteina de transferencia de colesteril ester.
PY0117288A (es) Esteres oxigenados de acidos 4-yodo fenilamino benzhidroxamicos
GB0402137D0 (en) Novel compounds
NZ542616A (en) P38 inhibitors and methods of use thereof
SG148201A1 (en) Substituted imidazo ring systems and methods
GB0402143D0 (en) Novel compounds
DE602004030334D1 (de) Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen
GB0209891D0 (en) Novel compounds
CY1107846T1 (el) Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
UY29041A1 (es) Derivados de amino-piperidina, su preparacion y su utilización en terapeutica
ATE466583T1 (de) Viskoelastische substanzen zur verwendung bei mittelohr operationen
DOP2003000565A (es) Esteres hidroxamato del acido n-(4-fenil sustituido)- antranilico
EA200800716A1 (ru) Новая кристаллическая форма производного пиридазино[4,5-в]индола
ATE466073T1 (de) Basalmedium zur kultivierung von es-zellen
MXPA05009014A (es) Antagonistas del receptor ccr-3.
UY3465Q (es) Producto con piezas suspendidas
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
IL206440A0 (en) Use of il-17 for maturation of oocytes
BRPI0514584A (pt) método para preparar irbesartan e intermediários do mesmo
DK1697504T3 (da) Anvendelse af IL-6-type cytokiner til modning af oocytter
AU2003210850A1 (en) N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
NO20072159L (no) Anvendelse av graviditetsspesifikt glykoprotein til modning av oocytter

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

MM1K Lapsed by not paying the annual fees